U.S. Markets close in 3 hrs 53 mins
  • Here's the question a rejected job candidate emailed after her interview that eventually got her hired for another role
    Business
    Business Insider21 hours ago

    Here's the question a rejected job candidate emailed after her interview that eventually got her hired for another role

    According to Alexandra Cavoulacos and Kathryn Minshew, authors of "The New Rules of Work," it's not only possible to find out why the company turned you down — it's often advisable. Cavoulacos and Minshew are the cofounders — and COO and CEO, respectively, of careers advice and job listings site The Muse. In the book, they recommend following up with the hiring manager to ask for feedback on your interview skills.

  • Goldman has figured out the trick for making money off Amazon
    Business
    CNBC.com23 hours ago

    Goldman has figured out the trick for making money off Amazon

    Goldman has figured out the trick to making money off Amazon    8 Hours Ago | 00:39 Goldman Sachs gave its clients the best way to trade Amazon's stock and it basically came down to this: buy the shares when CEO Jeff Bezos takes out his wallet and ramps up spending. The firm cited its analysis of the company's previous three large investment cycles. It revealed shareholders saw a 44 percent return, on average, if they bought Amazon when its trailing 12-month capital expenditure spending growth first increased, versus a much lower 12 percent return if they bought when investment spending growth decreased. "While these stretches have often raised investor questions around long-term profitability,

  • Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug
    Business
    Zacks4 hours ago

    Biotech Stock Roundup: Biogen Gains on Strong Q1, NASH Data on Gilead Drug

    Earnings season for the biotech sector is off to a promising start with Biogen BIIB reporting better-than-expected first quarter results. While focus remained on Biogen’s results, companies like Gilead GILD were also in the news on the presentation of pipeline data. Biogen Up on Q1 Results: Biogen’s shares were up 3.6% on strong first quarter results with both revenues and earnings surpassing expectations.